Analystreport

Progenics Pharmaceuticals, Inc. (NASDAQ: PGNX) is now covered by analysts at Credit Suisse Group AG. They set an "outperform" rating on the stock.

PROGENICS PHARMACEUTICALS  (PGNX) 
Last progenics pharmaceuticals earnings: 8/9 07:30 am Check Earnings Report
US:NASDAQ Investor Relations: progenics.com